These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 9171858)

  • 1. Outpatient antibiotic therapy for febrile episodes in low-risk neutropenic patients with cancer.
    Escalante CP; Rubenstein EB; Rolston KV
    Cancer Invest; 1997; 15(3):237-42. PubMed ID: 9171858
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Outpatient antibiotic treatment in low-risk febrile neutropenic cancer patients.
    Escalante CP; Rubenstein EB; Rolston KV
    Support Care Cancer; 1996 Sep; 4(5):358-63. PubMed ID: 8883229
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antimicrobial prophylaxis and outpatient management of fever and neutropenia in adults treated for malignancy: American Society of Clinical Oncology clinical practice guideline.
    Flowers CR; Seidenfeld J; Bow EJ; Karten C; Gleason C; Hawley DK; Kuderer NM; Langston AA; Marr KA; Rolston KV; Ramsey SD
    J Clin Oncol; 2013 Feb; 31(6):794-810. PubMed ID: 23319691
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oral antibiotics with early hospital discharge compared with in-patient intravenous antibiotics for low-risk febrile neutropenia in patients with cancer: a prospective randomised controlled single centre study.
    Innes HE; Smith DB; O'Reilly SM; Clark PI; Kelly V; Marshall E
    Br J Cancer; 2003 Jul; 89(1):43-9. PubMed ID: 12838298
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Possibilities and limits of ambulatory supportive measures in oncology exemplified by antibiotic therapy of febrile neutropenia].
    Karthaus M; Meran JG; Geissler RG; Böhme A; Jürgens H; Ganser A
    Wien Med Wochenschr; 1998; 148(18):427-32. PubMed ID: 9888179
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Domiciliary treatment of febrile episodes in cancer patients: a prospective randomized trial comparing oral versus parenteral empirical antibiotic treatment.
    Minotti V; Gentile G; Bucaneve G; Iori AP; Micozzi A; Cavicchi F; Barbabietola G; Landonio G; Menichetti F; Martino P; Del Favero A
    Support Care Cancer; 1999 May; 7(3):134-9. PubMed ID: 10335931
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Outpatient management of febrile episodes in neutropenic cancer patients.
    Rubenstein EB; Rolston K
    Support Care Cancer; 1994 Nov; 2(6):369-73. PubMed ID: 7858928
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oral versus intravenous antibiotic treatment for febrile neutropenia in cancer patients: a systematic review and meta-analysis of randomized trials.
    Vidal L; Paul M; Ben dor I; Soares-Weiser K; Leibovici L
    J Antimicrob Chemother; 2004 Jul; 54(1):29-37. PubMed ID: 15201227
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Feasibility of outpatient management of fever in cancer patients with low-risk neutropenia: results of a prospective randomized trial.
    Malik IA; Khan WA; Karim M; Aziz Z; Khan MA
    Am J Med; 1995 Mar; 98(3):224-31. PubMed ID: 7872337
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Randomized trial of oral versus intravenous antibiotics in low-risk febrile neutropenic patients with lung cancer.
    Niho S; Ohe Y; Goto K; Ohmatsu H; Matsumoto T; Kubota K; Kakinuma R; Nishiwaki Y
    Jpn J Clin Oncol; 2004 Feb; 34(2):69-73. PubMed ID: 15067098
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early empiric antibiotic therapy for febrile neutropenia patients at low risk.
    Rolston KV; Rubenstein EB; Freifeld A
    Infect Dis Clin North Am; 1996 Jun; 10(2):223-37. PubMed ID: 8803619
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A double-blind comparison of empirical oral and intravenous antibiotic therapy for low-risk febrile patients with neutropenia during cancer chemotherapy.
    Freifeld A; Marchigiani D; Walsh T; Chanock S; Lewis L; Hiemenz J; Hiemenz S; Hicks JE; Gill V; Steinberg SM; Pizzo PA
    N Engl J Med; 1999 Jul; 341(5):305-11. PubMed ID: 10423464
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Outpatient, sequential, parenteral-oral antibiotic therapy for lower risk febrile neutropenia in children with malignant disease: a single-center, randomized, controlled trial in Argentina.
    Paganini H; Gómez S; Ruvinsky S; Zubizarreta P; Latella A; Fraquelli L; Iturres AS; Casimir L; Debbag R
    Cancer; 2003 Apr; 97(7):1775-80. PubMed ID: 12655535
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oral versus intravenous antibiotics in treatment of paediatric febrile neutropenia.
    Vedi A; Cohn R
    J Paediatr Child Health; 2013 Mar; 49(3):170-8. PubMed ID: 22136103
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Outcomes of treatment pathways in outpatient treatment of low risk febrile neutropenic cancer patients.
    Escalante CP; Weiser MA; Manzullo E; Benjamin R; Rivera E; Lam T; Ho V; Valdres R; Lee EL; Badrina N; Fernandez S; DeJesus Y; Rolston K
    Support Care Cancer; 2004 Sep; 12(9):657-62. PubMed ID: 15185134
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The outpatient management of febrile neutropenia in cancer patients.
    Freifeld AG; Pizzo PA
    Oncology (Williston Park); 1996 Apr; 10(4):599-606, 611-2; discussion 615-6. PubMed ID: 8723296
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of empiric antibiotic de-escalation in febrile neutropenia.
    Kroll AL; Corrigan PA; Patel S; Hawks KG
    J Oncol Pharm Pract; 2016 Oct; 22(5):696-701. PubMed ID: 26227319
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oral versus intravenous antibiotic treatment for febrile neutropenia in cancer patients.
    Vidal L; Paul M; Ben-Dor I; Pokroy E; Soares-Weiser K; Leibovici L
    Cochrane Database Syst Rev; 2004 Oct; (4):CD003992. PubMed ID: 15495074
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Empirical oral antibiotic therapy for low risk febrile cancer patients with neutropenia.
    Koh A; Pizzo PA
    Cancer Invest; 2002; 20(3):420-33. PubMed ID: 12025236
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oral ciprofloxacin in the management of children with cancer with lower risk febrile neutropenia.
    Paganini H; Rodriguez-Brieshcke T; Zubizarreta P; Latella A; Firpo V; Casimir L; Armada A; Fernández C; Cáceres E; Debbag R
    Cancer; 2001 Apr; 91(8):1563-7. PubMed ID: 11301406
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.